DE69018799D1 - IGF-I zur Behandlung von Nebeneffekten der Steroidtherapie. - Google Patents

IGF-I zur Behandlung von Nebeneffekten der Steroidtherapie.

Info

Publication number: DE69018799D1
Authority: DE; Germany
Prior art keywords: igf; treatment; side effects; steroid therapy; steroid
Prior art date: 1989-12-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69018799T

Other languages

English (en)

Other versions

DE69018799T2 (de

Inventor

Ronald L Goldberg

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis AG

Original Assignee

Ciba Geigy AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-22

Filing date

1990-12-13

Publication date

1995-05-24

1990-12-13 Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG

1995-05-24 Publication of DE69018799D1 publication Critical patent/DE69018799D1/de

1995-09-21 Application granted granted Critical

1995-09-21 Publication of DE69018799T2 publication Critical patent/DE69018799T2/de

2010-12-14 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Toxicology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines Containing Plant Substances (AREA)

DE69018799T 1989-12-22 1990-12-13 IGF-I zur Behandlung von Nebeneffekten der Steroidtherapie. Expired - Fee Related DE69018799T2 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US45521589A	1989-12-22	1989-12-22

Publications (2)

Publication Number	Publication Date
DE69018799D1 true DE69018799D1 (de)	1995-05-24
DE69018799T2 DE69018799T2 (de)	1995-09-21

Family

ID=23807878

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69018799T Expired - Fee Related DE69018799T2 (de)	1989-12-22	1990-12-13	IGF-I zur Behandlung von Nebeneffekten der Steroidtherapie.

Country Status (14)

Country	Link
EP (1)	EP0434625B1 (de)
JP (1)	JP2934023B2 (de)
KR (1)	KR100191381B1 (de)
AT (1)	ATE121296T1 (de)
AU (1)	AU641966B2 (de)
CA (1)	CA2032859C (de)
DE (1)	DE69018799T2 (de)
DK (1)	DK0434625T3 (de)
ES (1)	ES2071080T3 (de)
GR (1)	GR3015900T3 (de)
IE (1)	IE67510B1 (de)
IL (1)	IL96711A (de)
NZ (1)	NZ236614A (de)
ZA (1)	ZA9010332B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5128320A (en) *	1990-01-18	1992-07-07	Genentech, Inc.	Method of restoring normal growth, weight gain or lean body mass in patients with glucocorticoid excess by administering igf-i
TW267102B (de)	1992-03-13	1996-01-01	Ciba Geigy
US5407913A (en) *	1992-12-03	1995-04-18	Celtrix Pharmaceuticals, Inc.	Method and composition for systemic treatment of tissue injury
US5712249A (en) *	1994-09-08	1998-01-27	Ciba-Geigy Corporation	Use of insulin-like growth factors I and II for inhibition of inflammatory response
AU3545795A (en) *	1994-09-08	1996-03-27	Chiron Corporation	A method of improved production of insulin-like growth factor
WO1997015319A1 (en) *	1995-10-23	1997-05-01	Queen's University At Kingston	Method and pharmaceutical composition for chondrostimulation with a prostaglandin (e.g. misoprostol) and tgf-beta, optionally in combination with igf-1
US5985830A (en) *	1996-09-16	1999-11-16	Dalhousie University	Use of IGF-I for the treatment of kidney disorders
US6015786A (en) *	1997-02-25	2000-01-18	Celtrix Pharmaceuticals, Inc.	Method for increasing sex steroid levels using IGF or IGF/IGFBP-3
US6025368A (en) *	1997-02-25	2000-02-15	Celtrix Pharmaceuticals, Inc.	Method for treating the symptoms of chronic stress-related disorders using IGF
US6514937B1 (en)	1997-02-25	2003-02-04	Celtrix Pharmaceuticals, Inc.	Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
AU3548999A (en)	1998-04-03	1999-10-25	Chiron Corporation	Use of igfi for treating articular cartilage disorders
IL143866A0 (en)	1999-01-06	2002-04-21	Genentech Inc	Insulin-like growth factor (igf) i mutant variants
AU2001263215A1 (en)	2000-05-16	2001-11-26	Genentech Inc.	Method for treating cartilage disorders
AU2006275444B2 (en)	2005-08-01	2010-10-28	Genera Istrazivanja D.O.O.	Methods and compositions for regenerating articular cartilage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0289584B1 (de) *	1986-11-14	1993-05-05	Institute of Molecular Biology, Inc.	Wundheilung und knochenregeneration
SE8703625D0 (sv) *	1987-09-18	1987-09-18	Kabivitrum Ab	New medical use
US4983581A (en) *	1988-05-20	1991-01-08	Institute Of Molecular Biology, Inc.	Wound healing composition of IGF-I and TGF-β

1990
- 1990-12-12 ZA ZA9010332A patent/ZA9010332B/xx unknown
- 1990-12-13 DE DE69018799T patent/DE69018799T2/de not_active Expired - Fee Related
- 1990-12-13 DK DK90810987.9T patent/DK0434625T3/da active
- 1990-12-13 ES ES90810987T patent/ES2071080T3/es not_active Expired - Lifetime
- 1990-12-13 EP EP90810987A patent/EP0434625B1/de not_active Expired - Lifetime
- 1990-12-13 AT AT90810987T patent/ATE121296T1/de not_active IP Right Cessation
- 1990-12-18 IL IL9671190A patent/IL96711A/en not_active IP Right Cessation
- 1990-12-19 AU AU68247/90A patent/AU641966B2/en not_active Ceased
- 1990-12-20 CA CA002032859A patent/CA2032859C/en not_active Expired - Fee Related
- 1990-12-20 KR KR1019900021111A patent/KR100191381B1/ko not_active Expired - Fee Related
- 1990-12-21 IE IE468490A patent/IE67510B1/en not_active IP Right Cessation
- 1990-12-21 NZ NZ236614A patent/NZ236614A/xx unknown
- 1990-12-21 JP JP2405132A patent/JP2934023B2/ja not_active Expired - Fee Related
1995
- 1995-04-20 GR GR950400745T patent/GR3015900T3/el unknown

Also Published As

Publication number	Publication date
AU6824790A (en)	1991-06-27
KR100191381B1 (ko)	1999-06-15
EP0434625A2 (de)	1991-06-26
ATE121296T1 (de)	1995-05-15
ZA9010332B (en)	1991-08-28
CA2032859C (en)	2007-09-17
GR3015900T3 (en)	1995-07-31
EP0434625B1 (de)	1995-04-19
IL96711A0 (en)	1991-09-16
IE904684A1 (en)	1991-07-17
NZ236614A (en)	1993-10-26
ES2071080T3 (es)	1995-06-16
IL96711A (en)	1996-01-19
AU641966B2 (en)	1993-10-07
EP0434625A3 (en)	1991-10-02
CA2032859A1 (en)	1991-06-23
IE67510B1 (en)	1996-04-03
DE69018799T2 (de)	1995-09-21
JP2934023B2 (ja)	1999-08-16
KR910011279A (ko)	1991-08-07
JPH04210648A (ja)	1992-07-31
DK0434625T3 (da)	1995-06-26

Publication	Publication Date	Title
ATE121296T1 (de)	1995-05-15	Igf-i zur behandlung von nebeneffekten der steroidtherapie.
DE69016768D1 (de)	1995-03-23	Zusammensetzung und Verfahren für die Behandlung von Osteoporose bei Säugetieren.
ATE187889T1 (de)	2000-01-15	Vorbeugung und behandlung der peripheren neuropathie
ES2113857T3 (es)	1998-05-16	Composiciones osteoinductoras.
DE69230344D1 (de)	1999-12-30	Zusammensetzungen und methoden zur wundbehandlung
ATE223486T1 (de)	2002-09-15	Bmp-9 zusammensetzungen
DE122009000012I1 (de)	2011-12-01	Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE60013266D1 (de)	2004-09-30	Steroidnitrate zur behandlung von oxidativen schädigungen und endothelialer dysfunktion
DE69509843D1 (de)	1999-07-01	Apparat zur Behandlung z.B. von Poststücken
DE3851584D1 (de)	1994-10-27	Gegen Allergie wirkende Benzothiophene und neue und andere ausgewählte Benzothiophene, beide mit Wirkung zur Behandlung von akuten Atmungsangstanzeichen.
DE69431199D1 (de)	2002-09-26	Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
ATE178206T1 (de)	1999-04-15	Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
DE69301750D1 (de)	1996-04-18	Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose
ATE110961T1 (de)	1994-09-15	Behandlung von beatmungsabhängigkeit mit wachstumshormon.
ATE127118T1 (de)	1995-09-15	2-alkyl-3-benzoylbenzofurane zur behandlung von herzarrhythmia.

Legal Events

Date	Code	Title	Description
1996-05-15	8364	No opposition during term of opposition
1997-09-11	8327	Change in the person/name/address of the patent owner	Owner name: NOVARTIS AG, BASEL, CH
2006-10-26	8328	Change in the person/name/address of the agent	Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN
2009-07-30	8328	Change in the person/name/address of the agent	Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC
2009-10-22	8339	Ceased/non-payment of the annual fee